Jan Serroyen

2.0k citations

44 papers · 1.2k indexed · 1 hit paper · h-index 18

Impact in

Rheumatology top 5%
- Pelvic floor disorders treatments
Urology top 10%

Papers in

Infectious Diseases 11
- Viral gastroenteritis research and epidemiology 8
- Viral Infections and Outbreaks Research 4
Developmental Biology 1

Co-authors: Luc Smits Mark Spigt Luc Budé Daniel Kotz Wolfgang Viechtbauer Rik Crutzen Mirjam Weemhoff Frans J.M.E. Roumen
Journals: Vaccine (6 papers)npj Vaccines (4 papers)Vaccines (3 papers)International Urogynecology Journal (2 papers)The Journal of Urology (2 papers)
Partner nations: Netherlands Belgium United States

In The Last Decade

Jan Serroyen

42 papers receiving 1.2k citations

Hit Papers

align trajectories log scale

A simple formula for the calculation of sample size in pilot studies 2015 · 361 citations

Peers

Countries citing papers authored by Jan Serroyen

Since Specialization

Citations

This map shows the geographic impact of Jan Serroyen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Serroyen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Serroyen more than expected).

Fields of papers citing papers by Jan Serroyen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Serroyen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Serroyen. The network helps show where Jan Serroyen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jan Serroyen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jan Serroyen Line = papers co-authored together Jan Serroyen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Optimization of the drug-induced cholestasis index based on advanced modeling for predicting liver toxicity Toxicology ·SK Taunk, Vahid Nassiri, Yun-Ting Chang, Jan Serroyen, Emmanuel Gustin, Bruna dos Santos Rodrigues, Darren Moss, KK Ponnu Swamy, Mathieu Vinken, Freddy Van Goethem, Julen Sanz-Serrano	2025	1
2	The Biodistribution of the Spike Protein after Ad26.COV2.S Vaccination Is Unlikely to Play a Role in Vaccine-Induced Immune Thrombotic Thrombocytopenia Vaccines ·A I Galiev, Selina Khan, Simone Rhein, Laura Solforosi, L M M Costes, SU Ho, Jakub Michalczak, Mieke Verslegers, Marjolein van Heerden, J T Vetto, Sandra De Jonghe, Hendy Kristyanto, Veronica V. Rezelj, Jenny Hendriks, Jan Serroyen, Jeroen Tolboom, Frank Wegmann, Roland Zahn	2024	0
3	Peak transgene expression after intramuscular immunization of mice with adenovirus 26-based vector vaccines correlates with transgene-specific adaptive immune responses PLoS ONE ·A I Galiev, F. J. Murillo, Jan Serroyen, Roland Zahn, Selina Khan	2024	1
4	Combination Ad26.RSV.preF/preF protein vaccine induces superior protective immunity compared with individual vaccine components in preclinical models npj Vaccines ·Eiríkur Saeland, Leslie van der Fits, Yigang Kong, Munezo Seki, Shubhangi H. Pawar, Susan Roy, آية مدحت شندي محمد, Lisanne Tettero, Freek Cox, Jan Serroyen, Matthew J. Jorgensen, Johannes P. M. Langedijk, Hanneke Schuitemaker, Benoît Callendret, Roland Zahn	2023	11
5	Intravenous Administration of Ad26.COV2.S Does Not Induce Thrombocytopenia or Thrombotic Events or Affect SARS-CoV-2 Spike Protein Bioavailability in Blood Compared with Intramuscular Vaccination in Rabbits Vaccines ·Selina Khan, A I Galiev, Tim Erkens, วิทวัส มงคล, L M M Costes, Petra Vinken, Sandra De Jonghe, J T Vetto, Tina Vaughn, Ronnie Chamanza, Jan Serroyen, Jeroen Tolboom, Roland Zahn, Frank Wegmann	2023	1
6	Immunogenicity and protective efficacy of adenoviral and subunit RSV vaccines based on stabilized prefusion F protein in pre-clinical models Vaccine ·Eiríkur Saeland, Leslie van der Fits, Yigang Kong, Munezo Seki, Shubhangi H. Pawar, Susan Roy, آية مدحت شندي محمد, Lisanne Tettero, Jan Serroyen, Hanneke Schuitemaker, Benoît Callendret, Johannes P. M. Langedijk, Roland Zahn	2021	13
7	Adenovector 26 encoded prefusion conformation stabilized RSV-F protein induces long-lasting Th1-biased immunity in neonatal mice npj Vaccines ·Leslie van der Fits, Yigang Kong, Munezo Seki, Shubhangi H. Pawar, Susan Roy, Jan Serroyen, Johannes P. M. Langedijk, Hanneke Schuitemaker, Eiríkur Saeland, Roland Zahn	2020	20
8	Bayesian sequential integration within a preclinical pharmacokinetic and pharmacodynamic modeling framework: Lessons learned Pharmaceutical Statistics ·Corlina Fince Santalian, Tom Jacobs, Helena Geys, Thomas Jaki, Jan Serroyen, Moreno Ursino, Alberto Russu, Christel Faes	2019	4
9	Adenovectors encoding RSV-F protein induce durable and mucosal immunity in macaques after two intramuscular administrations npj Vaccines ·F. J. Murillo, Jon-Ivar Skullerud, Lucia Tattoli, Ryan Ali Mas'ud, Jan Serroyen, Jeroen Tolboom, Eiríkur Saeland, Hanneke Schuitemaker, Roland Zahn	2019	19
10	Adenovirus based HPV L2 vaccine induces broad cross-reactive humoral immune responses Vaccine ·Marija Vujadinovic, Selina Khan, Koen Oosterhuis, Taco G. Uil, Kerstin Wunderlich, Mariana Botero Muñoz, Jakub Michalczak, Annemiek Verwilligen, Eman Qattan, Jan Serroyen, Hanneke Schuitemaker, Roland Zahn, Gert C. Scheper, Jerome Custers, Jort Vellinga	2018	18
11	Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitro Vaccine ·Anne Marie Queenan, David J. Dowling, Hiroki Imanishi, Kellen C. Faé, Jeffrey Fernandez, Peter J. Flynn, C. Correa Feria, Spencer E. Brightman, Juan Camilo Ramírez, Jan Serroyen, Selma P. Wiertsema, Alvarez Melani, Germie van den Dobbelsteen, Ofer Levy, Jan Poolman	2018	14
12	An inactivated poliovirus vaccine using Sabin strains produced on the serum-free PER.C6® cell culture platform is immunogenic and safe in a non-human primate model Vaccine ·Viki Bockstal, Machteld M. Tiemessen, Asfidiqi Ashardianti, El Sherbini El Said Es, Ad M. Knaapen, Jan Serroyen, Wilfred E. Marissen, Hanneke Schuitemaker, Roland Zahn	2018	10
13	Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection in cotton rats Vaccine ·Myra N. Widjojoatmodjo, Lies Bogaert, Bob Meek, Roland Zahn, Jort Vellinga, Jerome Custers, Jan Serroyen, Katarina Radošević, Hanneke Schuitemaker	2015	46
14	Differential effects of proteins and carbohydrates on postprandial blood pressure-related responses British Journal Of Nutrition ·Дилбар Саттор Кизи Маматқулова, Jean Carlos Domingos, Johanna M. Geleijnse, Stephan J. L. Bakker, Elizabeth J. Brink, Peter W. de Leeuw, Jan Serroyen, Marleen A. van Baak	2014	15
15	The impact of personal attributes on the association between cumulative exposure to work stressors and cardiovascular disease Journal of Psychosomatic Research ·Nurul Aiman Farhana, Ludovic G. P. M. van Amelsvoort, Jan Serroyen, Martin H. Prins, Nicole Jansen, IJmert Kant	2013	3
16	Ischemia Index to predict post coronary artery bypass graft change in left ventricular ejection fraction Journal of Electrocardiology ·F Derkx-Verhagen, Galen S. Wagner, Dumbrăveanu Cătălina, Jan Serroyen, Anton P.M. Gorgels	2012	0
17	Advanced maternal age, short interpregnancy interval, and perinatal outcome American Journal of Obstetrics and Gynecology ·Giampaolo Armellin, Chantal W.P.M. Hukkelhoven, Jan Serroyen, Egbert R. te Velde, Luc Smits	2011	58
18	Postoperative catheterization after anterior colporrhaphy: 2 versus 5 days. A multicentre randomized controlled trial International Urogynecology Journal ·Mirjam Weemhoff, Martine Wassen, عبدالهادي عيدوسي, Jan Serroyen, D Lombardi, Frans J.M.E. Roumen	2010	22
19	Nonlinear Models for Longitudinal Data The American Statistician ·Jan Serroyen, Geert Molenberghs, Geert Verbeke, Marie Davidian	2009	44
20	Altered ingestive behavior, weight changes, and intact olfactory sense in an APP overexpression model. Behavioral Neuroscience ·Ellen Vloeberghs, Debby Van Dam, F. Franck, Jan Serroyen, Geert Molenberghs, Matthias Staufenbiel, Peter Paul De Deyn	2008	38

About Jan Serroyen

Jan Serroyen is a scholar working on Infectious Diseases, Developmental Biology, Statistics and Probability, Anesthesiology and Pain Medicine and Urology, having authored 44 papers that have together received 1.2k indexed citations. Recurring topics across this work include Virus-based gene therapy research (8 papers), Viral gastroenteritis research and epidemiology (8 papers), Respiratory viral infections research (5 papers), Viral Infections and Outbreaks Research (4 papers), Pelvic floor disorders treatments (3 papers), Cardiac electrophysiology and arrhythmias (3 papers), Statistical Methods and Bayesian Inference (3 papers) and Optimal Experimental Design Methods (3 papers). The work is most often cited by research in Rheumatology (177 citations), Urology (58 citations), Infectious Diseases (138 citations), Cardiology and Cardiovascular Medicine (152 citations) and Epidemiology (219 citations). Jan Serroyen has collaborated with scholars based in Netherlands, Belgium and United States. Frequent co-authors include Luc Smits, Mark Spigt, Luc Budé, Daniel Kotz, Wolfgang Viechtbauer, Rik Crutzen, Mirjam Weemhoff, Frans J.M.E. Roumen, Geert Molenberghs and Roland Zahn. Their work appears in journals such as Vaccine, npj Vaccines, Vaccines, International Urogynecology Journal and The Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact